Early histologic changes in fibrosing cholestatic hepatitis C
Open Access
- 4 January 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 13 (2), 219-226
- https://doi.org/10.1002/lt.21011
Abstract
Recurrent hepatitis C (RHCV) after liver transplantation is almost universal, and occasional patients will have an aggressive course characterized histologically by pericellular/sinusoidal fibrosis and cholestasis, known as fibrosing cholestatic hepatitis (FCH). The early stages and evolution of this disease have not been well characterized. A total of 77 liver biopsies performed for indication (nonprotocol) were evaluated for necroinflammation, rejection, cholestasis, and fibrosis. Control groups were composed of protocol biopsies from HCV transplant patients (10 biopsies) as well as non–HCV transplant patients (6 biopsies). Scoring for necroinflammation, rejection, and fibrosis were compiled using standard criteria (hepatic activity index, Banff, Ishak, METAVIR). Pericellular fibrosis was staged with a novel “sinusoidal” system. A cholestasis scoring system was developed to quantitate parenchymal and portal features of cholestasis. Biopsies were categorized as rejection, RHCV, FCH, and stable based on histology and clinical information. FCH was found to have a higher fibrosis stage overall when compared to most diagnostic groups, regardless of the staging system used. Additionally, sinusoidal fibrosis was significantly higher in the FCH diagnosis group. Cholestasis was more prominent in biopsies of FCH in all comparisons. In conclusion, the presence of cholestasis and fibrosis with mild to moderate RHCV should raise the suspicion of FCH. When studying the evolution of these cases, the first abnormality to appear is RHCV and cholestasis, fibrosis develops soon after, and both continue to worsen until the point of allograft failure or patient death. Liver Transpl, 2006. © 2006 AASLD.Keywords
This publication has 15 references indexed in Scilit:
- Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis CLiver Transplantation, 2005
- Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantationLiver Transplantation, 2005
- Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus–related graft cirrhosisLiver Transplantation, 2003
- Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?The Journal of Heart and Lung Transplantation, 1999
- High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodesHepatology, 1999
- Banff schema for grading liver allograft rejection: An international consensus documentHepatology, 1997
- Severe recurrent cholestatic hepatitis C following orthotopic liver transplantationHepatology, 1996
- CLINICAL AND HISTOLOGIC PATTERNS OF EARLY GRAFT FAILURE DUE TO RECURRENT HEPATITIS C IN FOUR PATIENTS AFTER LIVER TRANSPLANTATIONTransplantation, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisHepatology, 1991